Source: https://www.prarulebook.co.uk/pra-rules/disclosure-crr/01-01-2027?p=1 · captured 2026-09-28 · checked 2026-09-28 · e50731f3

1001
1002(d) a list of SSPEs falling into any of the following categories, with a description of their types of exposures to those SSPEs, including derivative contracts:
1003
1004(i) SSPEs which acquire exposures originated by the institutions;
1005
1006(ii) SSPEs sponsored by the institutions;
1007
1008(iii) SSPEs and other legal entities for which the institutions provide securitisation-related services, such as advisory, asset servicing or management services;
1009
1010(iv) SSPEs included in the institutions' regulatory scope of consolidation;
1011
1012(e) a list of any legal entities in relation to which the institutions have disclosed that they have provided support in accordance with Chapter 5 of Title II of Part Three;
1013
1014(f) a list of legal entities affiliated with the institutions and that invest in securitisations originated by the institutions or in securitisation positions issued by SSPEs sponsored by the institutions;
1015
1016(g) a summary of their accounting policies for securitisation activity, including where relevant a distinction between securitisation and resecuritisation positions;
1017
1018(h) the names of the ECAIs used for securitisations and the types of exposure for which each agency is used;
1019
1020(i) where applicable, a description of the Internal Assessment Approach as set out in Chapter 5 of Title II of Part Three, including the structure of the internal assessment process and relation between internal assessment and external ratings of the relevant ECAI disclosed in accordance with point (h), the control mechanisms for the internal assessment process including discussion of independence, accountability, and internal assessment process review, the exposure types to which the internal assessment process is applied and the stress factors used for determining credit enhancement levels;
1021
1022(j) separately for the trading book and the non-trading book, the carrying amount of securitisation exposures, including information on whether institutions have transferred significant credit risk in accordance with Articles 244 and 245, for which institutions act as originator, sponsor or investor, separately for traditional and synthetic securitisations, and for STS and non-STS transactions and broken down by type of securitisation exposures;
1023
1024(k) for the trading and the non-trading book activities, the following information:
1025
1026(i) the aggregate amount of securitisation positions where institutions act as originator or sponsor and the associated risk-weighted assets and capital requirements by regulatory approaches, including exposures deducted from own funds or risk weighted at 1250%, broken down between traditional and synthetic securitisations and between securitisation and resecuritisation exposures, separately for STS and non-STS positions, and further broken down into a meaningful number of risk-weight or capital requirement bands and by approach used to calculate the capital requirements ;
1027
1028(ii) the aggregate amount of securitisation positions where institutions act as investor and the associated risk-weighted assets and capital requirements by regulatory approaches, including exposures deducted from own funds or risk weighted at 1250%, broken down between traditional and synthetic securitisations, securitisation and resecuritisation positions, and STS and non-STS positions, and further broken down into a meaningful number of risk weight or capital requirement bands and by approach used to calculate the capital requirements;
1029
1030(l) for exposures securitised by the institution, the amount of exposures in default and the amount of the specific credit risk adjustments made by the institution during the current period, both broken down by exposure type.
1031
1032[Note: This rule corresponds to Article 449 of the CRR as it applied immediately before revocation by the Treasury.]
1033
103401/01/2027
1035
1036Article 450 Disclosure of Remuneration Policy
1037
10381.
1039
1040Institutions shall disclose the following information regarding their remuneration policy and practices for those categories of staff whose professional activities have a material impact on risk profile of the institutions:
1041
1042(a) information concerning the decision-making process used for determining the remuneration policy, as well as the number of meetings held by the main body overseeing remuneration during the financial year, including, where applicable, information about the composition and the mandate of a remuneration committee, the external consultant whose services have been used for the determination of the remuneration policy and the role of the relevant stakeholders;
1043
1044(b) information about the link between pay of the staff and their performance;
1045
1046(c) the most important design characteristics of the remuneration system, including information on the criteria used for performance measurement and risk adjustment, deferral policy and vesting criteria;
1047
1048(d) the ratios between fixed and variable remuneration set in accordance with rule 15.9 of the Remuneration Part;
1049
1050(e) information on the performance criteria on which the entitlement to shares, options or variable components of remuneration is based;
1051
1052(f) the main parameters and rationale for any variable component scheme and any other non-cash benefits;
1053
1054(g) aggregate quantitative information on remuneration, broken down by business area;
1055
1056(h) aggregate quantitative information on remuneration, broken down by senior management and members of staff whose professional activities have a material impact on the risk profile of the institutions, indicating the following:
1057
1058(i) the amounts of remuneration for the financial year, split into fixed remuneration including a description of the fixed components, and variable remuneration, and the number of beneficiaries;
1059
1060(ii) the amounts and forms of awarded variable remuneration, split into cash, shares, share-linked instruments and other types separately for the part paid upfront and the deferred part;
1061
1062(iii) the amounts of deferred remuneration awarded for previous performance periods, split into the amount due to vest in the financial year and the amount due to vest in subsequent years;
1063
1064(iv) the amount of deferred remuneration due to vest in the financial year, and the number of beneficiaries of those awards;
1065
1066(v) the guaranteed variable remuneration awards during the financial year, and the number of beneficiaries of those awards;
1067
1068(vi) severance payments awarded in previous periods, that have been paid out during the financial year;
1069
1070(vii) the amounts of severance payments awarded during the financial year, split into paid upfront and deferred, the number of beneficiaries of those payments and highest payment that has been awarded to a single person;
1071
1072(i) the number of individuals that have been remunerated EUR 1 million or more per financial year, with the remuneration between EUR 1 million and EUR 5 million broken down into pay bands of EUR 500 000 and with the remuneration of EUR 5 million and above broken down into pay bands of EUR 1 million;
1073
1074(j) [Note: Provision deleted]
1075
1076(k) information on whether the institution benefits from a derogation laid down in the Remuneration Part of the PRA Rulebook at 5.3, and/or 12.2 (second subparagraph), and 15.A1(3).
1077
1078For the purposes of point (k) of the first subparagraph of this paragraph, institutions that benefit from such a derogation shall indicate whether they benefit from that derogation on the basis of the Remuneration Part of the PRA Rulebook at 5.3, and/or 12.2 (second subparagraph), and 15.A1(3). They shall also indicate for which of the remuneration principles they apply the derogation(s), the number of staff members that benefit from the derogation(s) and their total remuneration, split into fixed and variable remuneration.
1079
108031/10/2023
1081
10822.
1083
1084For large institutions, the quantitative information on the remuneration of institutions' collective management body referred to in this Article shall also be made available to the public, differentiating between executive and non-executive members.
1085
1086Institutions shall comply with the requirements set out in this Article in a manner that is appropriate to their size, internal organisation and the nature, scope and complexity of their activities and without prejudice to the GDPR.
1087
1088[Note: This rule corresponds to Article 450 of the CRR as it applied immediately before revocation by the Treasury.]
1089
109001/01/2022
1091
1092Article 451 Disclosure of the Leverage Ratio
1093
10941.
1095
1096Institutions shall disclose the following information regarding their leverage ratio as calculated in accordance with Article 429 of Chapter 3 of the Leverage Ratio (CRR) Part and their management of the risk of excessive leverage:
1097
1098(a) the leverage ratio;
1099
1100(b) the leverage ratio calculated as if central bank claims were required to be included in the total exposure measure;